Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma

Introduction: The role of surgery for early stage malignant pleural mesothelioma (MPM) remains controversial. Current expert opinion is only to treat patients surgically as part of multimodality therapy. It is still challenging to identify patients who will not benefit from surgery. We specifically...

Full description

Bibliographic Details
Main Authors: Robert A. Belderbos, MD, Alexander P.W.M. Maat, MD, Sara J. Baart, PhD, Eva V.E Madsen, MD, PhD, Ad J.J.C. Bogers, MD, PhD, Robin Cornelissen, MD, PhD, Joachim G.J.V. Aerts, MD, PhD, Edris A.F. Mahtab, MD, PhD, Jan H. von der Thüsen, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:JTO Clinical and Research Reports
Subjects:
Malignant pleural mesothelioma
ki-67
MTAP
Prognostic marker
Extended pleurectomy decortication
Online Access:http://www.sciencedirect.com/science/article/pii/S266636432100014X

Internet

http://www.sciencedirect.com/science/article/pii/S266636432100014X

Similar Items